Matches in Nanopublications for { ?s ?p "[In contrast to previous studies that did not identify differences between the 2 histological types, our results reveal that low expression of SP1 is involved in cancer progression and metastasis and differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 15 of
15
with 100 items per page.
- NP699808.RAYRb_68qbvgb3F4zlUOiYmEelLY5_FZDn6YncjVtZM3U130_assertion description "[In contrast to previous studies that did not identify differences between the 2 histological types, our results reveal that low expression of SP1 is involved in cancer progression and metastasis and differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP699808.RAYRb_68qbvgb3F4zlUOiYmEelLY5_FZDn6YncjVtZM3U130_provenance.
- NP930846.RARHP4JcTNFBOmPLFuRTRhMpF2pEY7PaZo6Xwx-EbaIek130_assertion description "[In contrast to previous studies that did not identify differences between the 2 histological types, our results reveal that low expression of SP1 is involved in cancer progression and metastasis and differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930846.RARHP4JcTNFBOmPLFuRTRhMpF2pEY7PaZo6Xwx-EbaIek130_provenance.
- NP891567.RAsxvuFc_AVYJs8HGBgLn4TjXuVLGJogTBEREUw_dRnlM130_assertion description "[In contrast to previous studies that did not identify differences between the 2 histological types, our results reveal that low expression of SP1 is involved in cancer progression and metastasis and differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP891567.RAsxvuFc_AVYJs8HGBgLn4TjXuVLGJogTBEREUw_dRnlM130_provenance.
- NP809692.RAky9Xf43oWjIEpNa-bMTuf6wTZA7fxgZFzHtmV4zS6r4130_assertion description "[In contrast to previous studies that did not identify differences between the 2 histological types, our results reveal that low expression of SP1 is involved in cancer progression and metastasis and differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809692.RAky9Xf43oWjIEpNa-bMTuf6wTZA7fxgZFzHtmV4zS6r4130_provenance.
- NP353887.RAGc5vALwcyvdCQbeafPOYpdqI44puNydH38bc6MKMfSM130_assertion description "[In contrast to previous studies that did not identify differences between the 2 histological types, our results reveal that low expression of SP1 is involved in cancer progression and metastasis and differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353887.RAGc5vALwcyvdCQbeafPOYpdqI44puNydH38bc6MKMfSM130_provenance.
- NP709207.RAeanCV_h-Ac7hjOANQgzJ7DjZOmAfdSL5v5sZSaPnkhU130_assertion description "[In contrast to previous studies that did not identify differences between the 2 histological types, our results reveal that low expression of SP1 is involved in cancer progression and metastasis and differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709207.RAeanCV_h-Ac7hjOANQgzJ7DjZOmAfdSL5v5sZSaPnkhU130_provenance.
- NP709233.RARbn0yj7A_JYixD6r7_i6KlyH14-e6-YRXab-l-8dxmI130_assertion description "[In contrast to previous studies that did not identify differences between the 2 histological types, our results reveal that low expression of SP1 is involved in cancer progression and metastasis and differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709233.RARbn0yj7A_JYixD6r7_i6KlyH14-e6-YRXab-l-8dxmI130_provenance.
- NP709341.RASD763uGdZo4SFoXh5P-lQDBAShQLlJw78rbByCmFXhg130_assertion description "[In contrast to previous studies that did not identify differences between the 2 histological types, our results reveal that low expression of SP1 is involved in cancer progression and metastasis and differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709341.RASD763uGdZo4SFoXh5P-lQDBAShQLlJw78rbByCmFXhg130_provenance.
- NP1055589.RAXzF392x-I6AfaXw8fI8utVDIgINJztk45cjDDSE_X0U130_assertion description "[In contrast to previous studies that did not identify differences between the 2 histological types, our results reveal that low expression of SP1 is involved in cancer progression and metastasis and differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1055589.RAXzF392x-I6AfaXw8fI8utVDIgINJztk45cjDDSE_X0U130_provenance.
- assertion description "[In contrast to previous studies that did not identify differences between the 2 histological types, our results reveal that low expression of SP1 is involved in cancer progression and metastasis and differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In contrast to previous studies that did not identify differences between the 2 histological types, our results reveal that low expression of SP1 is involved in cancer progression and metastasis and differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In contrast to previous studies that did not identify differences between the 2 histological types, our results reveal that low expression of SP1 is involved in cancer progression and metastasis and differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP709253.RAuhIXBljesL8IlN3yzV3l0mzizxj0QqTtGxXPPlrWxKM130_assertion description "[In contrast to previous studies that did not identify differences between the 2 histological types, our results reveal that low expression of SP1 is involved in cancer progression and metastasis and differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709253.RAuhIXBljesL8IlN3yzV3l0mzizxj0QqTtGxXPPlrWxKM130_provenance.
- NP1055587.RAI7gxmFNhG6EGrq3bgMEMlewEQP9gleqN5KMAq1nYZf8130_assertion description "[In contrast to previous studies that did not identify differences between the 2 histological types, our results reveal that low expression of SP1 is involved in cancer progression and metastasis and differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1055587.RAI7gxmFNhG6EGrq3bgMEMlewEQP9gleqN5KMAq1nYZf8130_provenance.
- NP1055590.RAlC66vFIdnQuuDZ413Vx5WUt4RxmHnMTgCfTrxLPj7vs130_assertion description "[In contrast to previous studies that did not identify differences between the 2 histological types, our results reveal that low expression of SP1 is involved in cancer progression and metastasis and differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1055590.RAlC66vFIdnQuuDZ413Vx5WUt4RxmHnMTgCfTrxLPj7vs130_provenance.